Evidence map›Paper›PMID 26958915›Full record

ReviewAnnual review of virology2015

Retroviral Integrase: Then and Now.

Mark D Andrake, Anna Marie Skalka

Abstract readReview
In one paragraph

Review in Annual review of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mark D AndrakeInstitute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111; email: mark.andrake@fccc.edu , am_skalka@fccc.edu.
Anna Marie SkalkaInstitute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111; email: mark.andrake@fccc.edu , am_skalka@fccc.edu.

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Dietmar J Kappes · 1985 to 2026
$138.8M
INTEGRATION OF RETROVIRAL DNA--ACCESSING HOST TARGET DNAR01CA071515 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI KATZ, RICHARD ALAN · 1996 to 2016
$7.6M
STRUCTURE/FUNCTION OF INTEGRASER01AI040385 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI ANDRAKE, MARK DAVID · 1997 to 2016
$7.1M
Enhancing the Properties of HIV-1 Integrase and Determination of its Structure in Complex with DNA SubstratesR21AI118589 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI ANDRAKE, MARK DAVID · 2015 to 2016
$491k
NCI NIH HHS CA 06927NCI NIH HHS CA 71515NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA071515NIAID NIH HHS AI 040385NIAID NIH HHS AI 118589NIAID NIH HHS R01 AI040385NIAID NIH HHS R21 AI118589
6 · The paper itself

Abstract

The retroviral integrases are virally encoded, specialized recombinases that catalyze the insertion of viral DNA into the host cell's DNA, a process that is essential for virus propagation. We have learned a great deal since the existence of an integrated form of retroviral DNA (the provirus) was first proposed by Howard Temin in 1964. Initial studies focused on the genetics and biochemistry of avian and murine virus DNA integration, but the pace of discovery increased substantially with advances in technology, and an influx of investigators focused on the human immunodeficiency virus. We begin with a brief account of the scientific landscape in which some of the earliest discoveries were made, and summarize research that led to our current understanding of the biochemistry of integration. A more detailed account of recent analyses of integrase structure follows, as they have provided valuable insights into enzyme function and raised important new questions.

Indexed as

AnimalsHumansIntegrasesModels, MolecularRetroviridaeRetroviridae InfectionsViral ProteinsVirus IntegrationIntegrasesViral Proteinscore dimerintasomeintegraseprophageprovirusreaching dimer

Identifiers

PMID26958915
PMCPMC4810031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.